Published in Klin Wochenschr on June 15, 1969
Shock-wave lithotripsy of gallbladder stones. The first 175 patients. N Engl J Med (1988) 5.53
Extracorporeally induced destruction of kidney stones by shock waves. Lancet (1980) 4.25
First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J Urol (1982) 3.14
CC chemokine receptor 5 and renal-transplant survival. Lancet (2001) 2.82
Fragmentation of gallstones by extracorporeal shock waves. N Engl J Med (1986) 2.76
Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet (2001) 2.76
Influence of isoflurane, fentanyl, thiopental, and alpha-chloralose on formation of brain edema resulting from a focal cryogenic lesion. Anesth Analg (1995) 2.01
Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology (1997) 1.95
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90
Necrosectomy and postoperative local lavage in necrotizing pancreatitis. Br J Surg (1988) 1.81
Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int (1993) 1.80
Duodenum-preserving resection of the head of the pancreas in severe chronic pancreatitis. Early and late results. Ann Surg (1989) 1.66
Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res (2000) 1.65
Reduced mortality and brain damage after locomotor activity in gerbil forebrain ischemia. Stroke (1994) 1.65
[Anesthesiologic efficacy of propanidid as a liposome dispersion. An experimental study with rats]. Anaesthesist (1992) 1.43
Valproate for epilepsy in renal transplant recipients receiving cyclosporine. Transplantation (1987) 1.42
Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol (1991) 1.42
Regional chemotherapy in liver metastases of colorectal carcinoma: monitoring with arterial computed tomography. Cancer Invest (1990) 1.40
Biological effects of shock waves: lung hemorrhage by shock waves in dogs--pressure dependence. Ultrasound Med Biol (1987) 1.39
Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene. Am J Kidney Dis (2001) 1.38
Evidence against leukotrienes as mediators of brain edema. J Neurosurg (1991) 1.38
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation (2000) 1.33
Shock waves for gallstones: animal studies. Lancet (1983) 1.25
A retrospective analysis of 3 year's experience of an interdisciplinary approach to gallstone disease including shock-waves. Ann Surg (1988) 1.19
Clinical pancreatic transplantation using the prolamine duct occlusion technique--the Munich experience. Transplant Proc (1987) 1.16
Biological effects of shock waves: kidney damage by shock waves in dogs--dose dependence. Ultrasound Med Biol (1988) 1.12
Biological effects of shock waves: kidney haemorrhage by shock waves in dogs--administration rate dependence. Ultrasound Med Biol (1988) 1.11
Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejection. Transplantation (1993) 1.11
Duodenum-preserving pancreatic head resection: Long-term results. J Gastrointest Surg (2006) 1.10
Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int (2001) 1.10
Early gallstone recurrence rate after successful shock-wave therapy. Gastroenterology (1990) 1.06
Stapling devices and their use in surgery. Prog Surg (1969) 1.05
Metabolic studies of type I diabetics after successful segmental pancreas and kidney transplantation. Transplant Proc (1990) 1.05
Prevalence of markers of hepatitis B in the adult German population. J Med Virol (2001) 1.04
Intensive immunosuppression in the treatment of multiple sclerosis. Lancet (1974) 1.04
Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia. Brain Res (2002) 1.03
Prolamine solution to block pancreatic duct. Lancet (1979) 1.03
Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J Cereb Blood Flow Metab (1988) 1.02
Effect of somatostatin analogue (SMS201-995) on cyclosporine levels. Transplantation (1987) 1.01
Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection. Infection (1987) 1.01
[Effect of tumor size and lymph node status on the prognosis of pancreatic cancer]. Chirurg (1989) 1.01
Low systemic exposure to tacrolimus correlates with acute rejection. Transplant Proc (1999) 0.99
A different clinical course of IDDM patients after simultaneous pancreas and kidney transplantation and kidney grafting alone. Transplant Proc (1990) 0.99
Glial swelling during extracellular acidosis in vitro. Stroke (1988) 0.98
Long-term results in pancreatic transplantation with special emphasis on the use of prolamine. Diabetologia (1991) 0.96
Combined kidney/pancreas transplantation--poor long-term outcome of renal grafts. Transplant Proc (1987) 0.96
Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid. Acta Neuropathol (1987) 0.96
Swelling, acidosis, and irreversible damage of glial cells from exposure to arachidonic acid in vitro. J Cereb Blood Flow Metab (1994) 0.96
Effects of bradykinin on permeability and diameter of pial vessels in vivo. J Cereb Blood Flow Metab (1984) 0.96
Production and effect of heterologous anti-canine lymphocyte serum. Surgery (1967) 0.95
Biological effects of shock waves: cell disruption, viability, and proliferation of L1210 cells exposed to shock waves in vitro. Ultrasound Med Biol (1990) 0.95
Vasomotor and permeability effects of bradykinin in the cerebral microcirculation. Immunopharmacology (1996) 0.94
Anesthetic methods in rats determine outcome after experimental focal cerebral ischemia: mechanical ventilation is required to obtain controlled experimental conditions. Brain Res Brain Res Protoc (2002) 0.94
Extracorporeal shock-wave lithotripsy of gallstones without general anesthesia: first clinical experience. Ann Intern Med (1987) 0.94
[Antilymphocyte serum therapy in human autoimmune diseases]. Klin Wochenschr (1968) 0.94
Incidence of fistulas following human pancreas transplantation--positive influence of reabsorption of pancreatic secretions by the peritoneum. Transplant Proc (1987) 0.93
Ulcer perforation in the grafted duodenal segment following pancreatic transplantation--a case report. Transplant Proc (1992) 0.93
Cerebral sinus and venous thrombosis in rats induces long-term deficits in brain function and morphology--evidence for a cytotoxic genesis. J Cereb Blood Flow Metab (1994) 0.93
Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol (1999) 0.93
[Therapeutic effect of heterologous antihuma lymphocyte serum (AHLS) in chronic lympahtic leukemia]. Klin Wochenschr (1968) 0.93
Total gastrectomy. A 15-year experience with particular reference to the patient over 70 years of age. Arch Surg (1985) 0.92
Therapeutic suggestions given during neurolept-anaesthesia decrease post-operative nausea and vomiting. Eur J Anaesthesiol (1998) 0.92
Electrolytes, fluids, and energy metabolism in human cerebral edema. Arch Neurol (1969) 0.91
The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: Inhibition of the kallikrein-kinin system in traumatic brain swelling. J Neurosurg (1986) 0.91
Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 0.91
Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc (2001) 0.90
The value of CA 19-9 in gastric and colorectal carcinoma. Cancer Invest (1987) 0.90
Influence of the shock wave application mode on the growth of A-Mel 3 and SSK2 tumors in vivo. Ultrasound Med Biol (1990) 0.90
The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma. Bull Cancer (1990) 0.90
Vascular complications in 1,200 kidney transplantations. Transplant Proc (1987) 0.89
Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders. Proc R Soc Med (1972) 0.89
[Bases of antilymphocytic globulin and its therapeutic possibilities]. Arzneimittelforschung (1970) 0.89
Application of a fibrinogen-thrombin-collagen-based hemostyptic agent in experimental injuries of liver and spleen. J Trauma (1988) 0.89
Successful transplantation of lungs topically cooled in the non-heart-beating donor for 6 hours. Ann Thorac Surg (1997) 0.89
[Orthotopic homotransplantation of the liver in the dog: immunosuppressive treatment with anti-lymphocyte serum]. Presse Med (1967) 0.89
Anaphylactoid reactions due to non-immune complex serum protein aggregates. Monogr Allergy (1977) 0.89
High sensitivity and specificity of CA 19-9 for pancreatic carcinoma in comparison to chronic pancreatitis. Serological and immunohistochemical findings. Pancreas (1987) 0.88
[Immunosuppressive therapy of multiple sclerosis. 1. Preliminary communication on the results of treatment with azathioprine and anti-lymphocytic globulin]. Munch Med Wochenschr (1971) 0.88
Anaphylactoid reactions to infusions of plasma protein and human serum albumin. Role of aggregated proteins and of stabilizers added during production. Clin Allergy (1979) 0.88
Letter: Prolongation of skin allografts in rats by treatment with linoleic acid. Lancet (1974) 0.88
Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats. J Neurotrauma (2001) 0.88
[Surprising results of intravenous therapy using antilymphocyte serum in organ transplantations]. Dtsch Med Wochenschr (1968) 0.88
Treatment of patients with severe head injury by triamcinolone: a prospective, controlled multicenter clinical trial of 396 cases. Res Exp Med (Berl) (1995) 0.88
A mechanism of gallstone destruction by extracorporeal shock waves. Naturwissenschaften (1988) 0.88
Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol. Neurosurgery (1995) 0.88
A model of extracorporeal shock wave action: tandem action of shock waves. Ultrasound Med Biol (1988) 0.88
Dominant role of complement in the hyperacute xenograft rejection reaction. Surg Gynecol Obstet (1976) 0.88
Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9. Hepatogastroenterology (1989) 0.88
Effects of lactacidosis on glial cell volume and viability. J Cereb Blood Flow Metab (1990) 0.87
Effect of lactacidosis on cell volume and intracellular pH of astrocytes. J Neurotrauma (1999) 0.87
Swelling and death of neuronal cells by lactic acid. J Neurol Sci (1993) 0.87
Glial ion transport and volume control. Ann N Y Acad Sci (1991) 0.87
The effectiveness of a fibrinogen-thrombin-collagen-based hemostatic agent in an experimental arterial bleeding model. Ann Surg (1987) 0.87
Volume regulation and metabolism of suspended C6 glioma cells: an in vitro model to study cytotoxic brain edema. Brain Res (1983) 0.85
Induction of tolerance in man to horse-IgG. Lancet (1969) 0.85